EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells

Maria Baena-Nuevo, Alba Vera-Zambrano, Carolina Martinez-Laperche, Ismael Buño, Cecilia Muñoz-Calleja, Carmen Valenzuela, Juan Manuel Zapata, Gema Perez-Chacon

European Journal of Pharmacology · 2025-11 · 1007 · 178281

DOI: 10.1016/j.ejphar.2025.178281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025-11. Verfasst von Maria Baena-Nuevo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Biomédicas Sols-Morreale, IIBM, CSIC-UAM, Madrid, Spain; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM…. Hauptthemen laut MEDLINE: Kv1.3 Potassium Channel, Leukemia, Lymphocytic, Chronic, B-Cell, Indoles, Potassium Channel Blockers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Ciencia e Innovación, European Commission, Spanish National Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Potassium voltage-gated channels are attractive drug targets for cancer treatment. In this report, we show that K V 1.3 current amplitude is greater in CLL cells from refractory patients compared to CLL cells from untreated patients, further supporting a role for Kv1.3 channel as a target for refractory CLL disease. Indole-3 carbinol (I3C) is a clinically tested natural product found in edible Brassica plants. Here we show that I3C inhibits K V 1.3 currents in transfected HEK293 (43.9 ± 7.6 %; 50 μM I3C), Burkitt´s lymphoma BL60.2 (52.2 ± 5.2 %; 10 μM) and chronic lymphocytic leukemia (CLL) (57.7% ± 5.2; 10 μM) cells. I3C inhibition was concentration-dependent in HEK293 (IC 50 = 54 μM; n H = 3.2), BL60.2 (IC 50 = 1.06 μM; n H = 0.53) and CLL (IC 50 = 5.2 μM; n H = 0.95) cells, and the effect on K V 1.3 was produced in a voltage-, time- and use-dependent manner, consistent with an open state blockade mechanism. I3C also inhibited K V 11.1 currents, but failed to inhibit other K V channels and K ca 3.1. Interestingly I3C did not induce mitochondrial depolarization of CLL cells, suggesting that I3C only targets plasma, but not mitochondria, Kv1.3 channels. I3C and derivatives 6-methyl-I3C and 3,3´-diindolylmethane, but no other indoles, that we previously showed induced apoptosis in Burkitt´s and CLL cells, also efficiently inhibited K V 1.3 currents. However, I3C-mediated K V 1.3 currents inhibition was observed in CLL cells irrespective of their sensitivity to I3C-induced cell death, thus indicating that plasma membrane K V 1.3 inhibition is not sufficient to induce CLL cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kv1.3 Potassium ChannelLeukemia, Lymphocytic, Chronic, B-CellIndolesPotassium Channel BlockersHumansHEK293 CellsCell Line, Tumor

Stichwörter der Autor:innen

B lymphocytesBurkitt's lymphomaChronic lymphocytic leukemiaDiindolylmethaneIndole-3-carbinolK(V)1.3 channels

Substanzen

Kv1.3 Potassium ChannelIndolesindole-3-carbinolPotassium Channel BlockersKCNA3 protein, human

Autor:innen und Institutionen

  • Instituto de Investigaciones Biomédicas Sols-Morreale, IIBM, CSIC-UAM, Madrid, Spain; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Spain.
  • Servicio de Hematología, Hospital G.U. Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Servicio de Inmunología, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa, Madrid, Spain.
  • Instituto de Investigaciones Biomédicas Sols-Morreale, IIBM, CSIC-UAM, Madrid, Spain; Network of Cardiovascular Diseases (CIBERCV), Spain.
  • Instituto de Investigaciones Biomédicas Sols-Morreale, IIBM, CSIC-UAM, Madrid, Spain; Instituto de Investigación Hospital Universitario La Paz (IDIPAZ), Madrid, Spain.
  • Instituto de Investigaciones Biomédicas Sols-Morreale, IIBM, CSIC-UAM, Madrid, Spain; Instituto de Investigación Hospital Universitario La Paz (IDIPAZ), Madrid, Spain. Electronic address: gema.perez@csic.es.

Förderung

  • Ministerio de Ciencia e Innovación
  • European Commission
  • Spanish National Research Council
  • Carlos III Health Institute
  • Comisión Sectorial de Investigación Científica
  • European Regional Development Fund
  • Community of Madrid Ministry of Health

Zitieren

APA

Baena-Nuevo, M., Vera-Zambrano, A., Martinez-Laperche, C., Buño, I., Muñoz-Calleja, C., Valenzuela, C., Zapata, J. M., & Perez-Chacon, G. (2025). Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells. European Journal of Pharmacology, 1007, 178281. https://doi.org/10.1016/j.ejphar.2025.178281

Vancouver

Baena-Nuevo M, Vera-Zambrano A, Martinez-Laperche C, Buño I, Muñoz-Calleja C, Valenzuela C, et al. Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells. European Journal of Pharmacology. 2025;1007:178281. doi:10.1016/j.ejphar.2025.178281

BibTeX
@article{BaenaNuevo2025,
  author = {Baena-Nuevo, Maria and Vera-Zambrano, Alba and Martinez-Laperche, Carolina and Buño, Ismael and Muñoz-Calleja, Cecilia and Valenzuela, Carmen and Zapata, Juan Manuel and Perez-Chacon, Gema},
  title = {Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells},
  journal = {European Journal of Pharmacology},
  year = {2025},
  volume = {1007},
  pages = {178281},
  doi = {10.1016/j.ejphar.2025.178281}
}
Kostenlos starten →